David Curiel, MD, PhD

Medical School Department Radiation Oncology
Research Program Oncologic Imaging
David Curiel

Researcher Background

Primary Academic Title

Professor of Radiation Oncology, Division of Cancer Biology, WashU Medicine

Training

  • 1982 - 1985: Intern and Resident, Internal Medicine, Emory University, Atlanta, GA
  • 1985 - 1989: Fellow, Pulmonary Medicine, National Heart, Lung and Blood Institute, Bethesda, MD
  • 1989 - 1990: Fellow, Biotechnology, Navy Medical Oncology Branch, National Cancer Institute, Bethesda, MD

Education

  • 1982: MD, Emory University, Atlanta, GA
  • 2002: PhD, Virology, University of Groningen, Groningen, Netherlands

Research & Selected Publications

Research Interest

Gene therapy, virotherapy and vaccinology.

Research Publications

Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma.
Authors:

Li YD, Giles DA, Huang Y, one or more additional authors omitted Curiel DT, one or more additional authors omitted Chheda MG

Journal & Year:

Nat Commun • 2026

Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation.
Authors:

Geng K, Rice-Boucher PJ, Kashentseva EA, one or more additional authors omitted Curiel DT

Journal & Year:

Viruses • 2023

Adenoviral vectors infect B lymphocytes in vivo.
Authors:

Rice-Boucher PJ, Mendonça SA, Alvarez AB, one or more additional authors omitted Curiel DT

Journal & Year:

Mol Ther • 2023